Endocrine effects of vasopressin in critically ill patients

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 2, 2008, Pages 265-273

  Sharshar, Tarek ^a   Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

aquaporin channels; atrial natriuretic peptides; free water; growth hormones; hypothalamic pituitary adrenal axis; prolactin; renin angiotensin system; vasopressin receptors

Indexed keywords

CORTICOSTEROID; DESMOPRESSIN; GLUCOSE; GROWTH HORMONE; INSULIN; NORADRENALIN; PROLACTIN; TERLIPRESSIN; VASOPRESSIN; VASOPRESSIN RECEPTOR; VASOPRESSIN V1B RECEPTOR;

ANTIDIURESIS; CONTINUOUS INFUSION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIABETES INSIPIDUS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE METABOLISM; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; HYPEROSMOTIC STRESS; HYPERVOLEMIA; HYPONATREMIA; HYPOOSMOTIC STRESS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSULIN SYNTHESIS; NONHUMAN; OSMOREGULATION; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; SEPTIC SHOCK; SHOCK; STEROIDOGENESIS; VASODILATATION; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; WATER RETENTION;

ADRENAL CORTEX HORMONES; ANIMALS; ANTIDIURETIC AGENTS; CRITICAL ILLNESS; ENDOCRINE GLANDS; HORMONES; HUMANS; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 44949124583     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2008.02.005     Document Type: Review

References (36)

1. Antunes-Rodrigues J., de Castro M., Elias L.L.K., et al. Neuroendocrine control of body fluid metabolism. Physiological Reviews 84 (2003) 169-208
2. Nielsen S., Chou C.L., Marples D., et al. A. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 1013-1017
3. Klussmann E., Maric K., and Rosenthal W. The mechanisms of aquaporin control in the renal collecting duct. Reviews of Physiology, Biochemistry and Pharmacology 141 (2000) 33-95
4. 2 receptor antagonist, in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics 282 (1997) 301-308
5. 2 vasopressin receptor antagonist in normal subjects. European Journal of Clinical Pharmacology 55 (1999) 633-637
6. 2 vasopressin receptor antagonist, in patients with advanced heart failure. Circulation 104 (2001) 2417-2423
7. Annane D, Decaux G, Smith N, for the Conivaptan Study Group. Efficacy and safety of oral Conivaptan, a vasopressin-receptor antagonist, avaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. The American Journal of the Medical Sciences, in press.
8. Chen J.M., Cillinane S., Spanier T.B., et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 100 (1999) II244-II246
9. Kinoshita Y., Yahata K., Yoshiota T., et al. Long term renal preservation after brain death maintained with vasopressin and epinephrine. Transplant International 3 (1990) 15-18
10. Patel B.M., Chittock D.R., Russel J.A., and Walley K.R. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96 (2002) 576-582
11. Dünser M.W., Mayr A.J., Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107 (2003) 2313-2319
12. Albanes J., Leone M., Delmas A., and Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Critical Care Medicine 33 (2005) 1897-1902
13. Versteilen A.M., Heemskerk A.E., Groenveld A.B., et al. Mechanisms of the urinary concentration defect and effect of desmopressin during endotoxemia in rats. Shock (2007 Jul 26) Publish Ahead of Print [Epub ahead of print]
14. Mc Cann S.M. The ACTH-releasing activity of extracts of the posterior lobe of the pituitary (in vivo). Endocrinology 137 (1957) 580-586
15. Conte-Devoix B., Oliver C., Giraud P., et al. Adrenocorticotropin, and corticosterone secretion in Brattleboro rats. Endocrinology 110 (1982) 2097-2100
16. Holmes M.C., Antoni F.A., Aguilera G., and Catt K.J. Magnocellular axons in passage through the median eminence release vasopressin. Nature 319 (1986) 326-329
17. Engelmann M., Landgraf R., and Wotjak C.T. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Frontiers in Neuroendocrinology 25 (2004) 132-149
18. Tanoue A., Ito S., Honda K., et al. The vasopressin V1b receptor critically regulates hypothalamic-pituitary adrenal axis activity under both stress and resting conditions. The Journal of Clinical Investigation 113 (2004) 302-309
19. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Frontiers in Neuroendocrinology 14 (1993) 76-122
20. Turnball A.V., Smith G.W., Lee S., et al. CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 140 (1999) 1013-1017
21. Wotjak C.T., Ludwig M., Ebner K., et al. Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion. The European Journal of Neuroscience 16 (2002) 477-485
22. Perraudin V., Delarue C., Lefebvre H., et al. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. The Journal of Clinical Endocrinology and Metabolism 76 (1993) 1522-1528
23. Guillon G., Trueba M., Joubert D., et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology 136 (1995) 1285-1295
24. Sharshar T., Blanchard A., Paillard M., et al. Circulating vasopressin levels in septic shock. Critical Care Medicine 31 (2003) 1752-1758
25. Oahwash I.M., Cassar C.A., Radcliff R.P., and Smith G.W. Bacterial lipopolysaccharide-induced coordinate downregulation of arginine vasopressine receptor V3 and corticotropin-releasing factor receptor 1 messenger ribonucleic acids in the anterior pituitary of endotoxemic steers. Endocrine 18 (2002) 13-20
26. Kornberger E., Prengel A.W., Krismer A., et al. Vasopressin-mediated adrenocorticotropin release increases plasma cortisol concentrations during cardiopulmonary resuscitation. Critical Care Medicine 28 (2000) 3517-3521
27. Lauzier F., Levy B., Lamarre P., and Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Medicine 32 (2006) 1782-1789
28. Tsuneyoshi I., Yamada H., Kakihana Y., et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Critical Care Medicine 29 (2001) 487-493
29. Itoh H., Nakao K., Yamada T., et al. Modulatory role of vasopressin in secretion of atrial natriuretic polypeptide in conscious rats. Endocrinology 120 (1987) 2186-2188
30. Cogan E., Debieve M.F., Philipart I., et al. High plasma levels of atrial natriuretic factor in SIADH. The New England Journal of Medicine 314 (1986) 1258-1259
31. Elias L.L., Antunes-Rodrigues J., Elias P.C., and Moreira A.C. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin - releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 1243-1247
32. Meller W.H., Lewis D.A., Gehris T.L., et al. Human anterior pituitary response to exogenous arginine vasopressin. Acta Endocrinologica (Copenh) 125 (1991) 378-384
33. Balakrishnan S.M., Gopalakrishnan V., and Mc Neill J.R. Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension. European Journal of Pharmacology 334 (1997) 55-60
34. Katoh K., Yoshida M., Kobayashi Y., et al. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats. The Journal of Endocrinology 187 (2005) 249-256
35. Szczepansaka-Sadowska E. Interaction of vasopressin and angiotensin II in central control of blood pressure and thirst. Regulatory Peptides 66 (1996) 65-71
36. Fujiwara Y., Hiroyama M., Sanbe A., et al. Insulin hypersensitivity in mice lacking the V1b vasopressin receptor. The Journal of Physiology 584 (2007) 235-244